Compass Therapeutics's total assets for Q2 2025 were $116.70M, a decrease of -11.22% from the previous quarter. CMPX total liabilities were $23.49M for the fiscal quarter, a 10.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.